Abstract We used comparative genomics and experimental analyses to show that (1) eukaryotes and archaea, which possess the selenocysteine (Sec) protein insertion machinery contain an enzyme, O-phosphoseryl-transfer RNA (tRNA) [Ser] , seryl-tRNA synthetase, PSTK, selenophosphate synthetase, and SecS. The enzyme that synthesizes monoselenophosphate is a previously identified selenoprotein, selenophosphate synthetase 2 (SPS2), whereas the previously identified mammalian selenophosphate synthetase 1 did not serve this function. Monoselenophosphate also served directly in the reaction replacing ATP, selenide, and SPS2, demonstrating that this compound was the active selenium donor. Conservation of the overall pathway of Sec biosynthesis suggests that this pathway is also active in other eukaryotes and archaea that contain selenoproteins.
Introduction
The selenium field has grown at a rapid pace over the last 15 to 20 years, and many new developments have occurred recently in the biochemistry and genetic areas of selenium research. Several thorough reviews have covered these topics [1] [2] [3] [4] . Herein, we have focused on recent developments involving the biosynthesis of selenocysteine (Sec) in eukaryotes and archaea that have not been reviewed elsewhere.
Sec is the 21st amino acid in the genetic code. It is cotranslationally inserted into protein in response to the codon, UGA [1] [2] [3] [4] . The biosynthesis of Sec occurs on its transfer RNA (tRNA), and the pathway begins with the initial aminoacylation of Sec tRNA with serine [5, 6] . Thus, the backbone for Sec is serine, and the identity elements in Sec tRNA for its aminoacylation correspond to those in seryl-tRNA synthetase [7, 8] . Sec tRNA has therefore been appropriately designated Sec tRNA [Ser] Sec [9] . Although the biosynthetic pathway for Sec was established in eubacteria more than 15 years ago [10] [11] [12] , only recently was the complete pathway for the biosynthesis of this amino acid elucidated in eukaryotes [13] . In Escherichia coli, the enzyme that synthesizes Sec, Sec synthase (SelA), was identified in the early 1990s and is a pyridoxal phosphate (PLP)-dependent protein [10] [11] [12] . SelA acts on the serine moiety attached to Sec tRNA [Ser] Sec by initially removing the hydroxyl group from serine to generate aminoacrylyl as an intermediate. Aminoacrylyl then accepts activated selenium to form selenocysteyl-tRNA [Ser] Sec . The activated selenium in bacteria is monoselenophosphate, and it is synthesized from selenide and adenosine triphosphate (ATP) by E. coli selenophosphate synthetase (SelD) [14] .
Several factors were previously characterized in higher vertebrates that were found to have a role in Sec biosynthesis. For example, a kinase that phosphorylated a minor seryltRNA to form O-phosphoseryl-tRNA was reported in rooster liver as early as 1970 [15] . This same year a minor seryl-tRNA from mammalian and chicken liver was found to decode specifically the termination codon, UGA [16] , which was subsequently shown to be the same tRNA that formed phosphoseryl-tRNA [17] . This tRNA was subsequently identified as Sec tRNA [Ser] Sec [6] . The kinase, designated O-phosphoseryl-tRNA
[Ser]Sec kinase (PSTK), was recently isolated, characterized, and found to specifically phosphorylate the seryl moiety on seryl-tRNA [Ser] Sec [18] . The resulting O-phosphoseryltRNA
[Ser]Sec product had been proposed as an intermediate in the biosynthesis of Sec [3, 18] . In addition, because no sequences with homology to SelA could be detected in eukaryotes, there was some question as to the identity of the Sec synthase (SecS) in mammals. The soluble liver antigen (SLA), which was initially identified as a 48-kDa protein bound to Sec tRNA [Ser] Sec and was targeted by antibodies in patients with an autoimmune chronic hepatitis [19] , was reported to occur as a separate family within a larger superfamily of diverse PLP-dependent transferases [20] and proposed as a possible SecS in mammals [3, [20] [21] [22] . SLA was also found to exist in a protein complex with other factors involved in Sec biosynthesis and/or its insertion into protein providing further evidence that this protein is involved in selenium metabolism [22, 23] . As described herein, SLA is indeed SecS in mammals [13] . In addition, two genes, sps1 and sps2, were found that had homology to SelD and the products of both genes were initially proposed to serve as selenophosphate synthetase (SPS) in mammals [24] [25] [26] [27] . Interestingly, sps2 encodes a selenoprotein, SPS2, which can serve, provided it is responsible for making the active selenium donor for the biosynthesis of Sec, as an autoregulator of selenoprotein synthesis [24, 26] . The Sec moiety in SPS2 was mutated to Cys, and the mutant has low enzyme activity [24, 26, 28] , but is capable of complementing SelD − E. coli cells transfected with the mammalian mutant form [28] . Additional studies involving the complementation of SelD − E. coli cells with either SPS2 or SPS1 suggested that SPS2 is involved in the synthesis of selenophosphate, whereas SPS1 has a role in recycling Sec via a selenium salvage pathway [29] .
We used a computational, comparative genomics approach to identify a single kinase with homologies common only to archaea and eukaryotes that utilize the Sec protein insertion machinery [18] . We also used a similar comparative genomics approach to identify SLA as the likely SecS [13] . These two studies demonstrate the potential of scanning even very distantly related genomes for new metabolic enzymes and the value of interdisciplinary research.
Each of the components discussed above, including tRNA [Ser] Sec , seryl-tRNA
Sec synthetase, PSTK, SLA, SPS2, and selenophosphate, finally were used to establish the biosynthetic pathway of the 21st amino acid in the genetic code in eukaryotes [13] . The fact that both SLA and PSTK sequences are found in eukaryotes and archaea that utilize the Sec protein insertion machinery, but not in those organisms that do not, provide strong evidence that this pathway is used by all eukaryotes and archaea that synthesize Sec-containing proteins ( [13, 18] and also see [30] ).
Discussion

Identifying Sec Kinase
We initially hypothesized that the pathway for synthesizing Sec was the same in those eukaryotes and archaea-making selenoproteins and that O-phosphoseryl-tRNA was a common intermediate [18] . Therefore, we compared the genomes of the two archaea that encode the Sec protein insertion machinery, Methanopyrus kandleri and Methanococccus jannaschii, to the 12 archaea whose genomes have been sequenced and do not encode the Sec insertion machinery for kinase-like genes using the BLASTN program [18] . There were two candidates found in the two archaea using Sec insertion machinery and not in the 12 other archaea. Interestingly, only one of these two protein genes, a predicted nucleotide kinase (gi: 20095115), had homologous sequences in eukaryotes encoding the Sec insertion machinery, but not in those eukaryotes whose genomes had been sequenced and lacked the Sec insertion machinery. The corresponding putative kinase gene (pstk) from mice was cloned into an expression vector, expressed, and the product purified and characterized [18] . The pstk coding sequence is 1,080 nucleotides that encodes a 359 amino acid protein. The resulting protein generated from the cloned expression vector used the serylated forms of mcm 5 U and mcm 5 Um as substrates to yield O-phosphoseryl-tRNA
[Ser]Sec . In addition to these two serylated isoforms, PSTK requires ATP and Mg ++ , and the reaction may be summarized as follows:
Even after the identification and characterization of PSTK [18] , its function was uncertain, as this kinase had been proposed to provide either a storage form of Sec tRNA
[Ser]Sec [31] or the intermediate in Sec biosynthesis [3, 18] . This issue was not resolved until the entire biosynthetic pathway of Sec was determined as described below.
Identifying SecS
The genomes of eukaryotes and archaea that had been completely sequenced were analyzed for the occurrence of selenoproteins, and comparative genomics studies were carried out to identify genes that co-occur with selenoproteins in these organisms [13] . Each search resulted in known components of the Sec insertion machinery and an additional protein that might be SecS in mammals. This additional protein had previously been detected in patients with autoimmune chronic hepatitis as an autoimmune factor that co-precipitated tRNA [Ser] Sec in cell extracts of these individuals and was known as the SLA [19] . SLA, which is a PLPdependent transferase [20] , also bound other protein components involved with Sec metabolism [22, 23] . We found that SLA occurred in all eukaryotes and archaea-encoding selenoproteins, but not in those organisms examined that lacked selenoproteins. These and other observations strongly suggested that SLA was the missing SecS in eukaryotes and archaea and that SelA from eubacteria and this potential SecS belonged to totally different families of PLP-containing proteins suggesting that their similar functions arose by convergent evolution [13] .
After identifying a potential SecS candidate by comparative genomics analysis as described above, we examined its function experimentally. The putative mouse SecS (mSecS) gene was cloned and expressed, and the binding of O-phosphoseryl-tRNA , as the product bound efficiently to mSecS, but seryl-tRNA
[Ser]Sec did not. Although these experiments suggested that mSecS was the mammalian SecS, it was essential to determine that the dephosphorylated product would accept the active selenium donor to form Sec before it could be concluded that mouse SLA was indeed the true Sec synthase in mammals. We therefore turned our attention to examining the functions of the two SPS, SPS1 and SPS2, to determine if either, or both, could produce the active selenium donor.
Identifying a Functional SPS in Mammals
To identify the active selenium donor, mouse sps1 (msps1) and sps2 (msps2) were individually cloned into an expression vector, and the Sec codon in msps2 converted to a Cys codon (msps2-Cys) [13] . Furthermore, because Caenorhabditis elegans sps2 (csps2) naturally encodes Cys at the active site in place of Sec found in mammals, csps2 was also cloned. We expressed msps1, msps2-Cys, csps2, and E. coli selD, purified the products, and assessed their abilities to synthesize monoselenophosphate (SeP) because, as noted in "Introduction," SeP is synthesized by SelD and had been identified as the active selenium donor in E. coli [10] [11] [12] . Each of these proteins was incubated separately with ATP and selenite under anaerobic conditions and a 31 P NMR spectrophotometric analysis of the products carried out. The mSPS2-Cys, cSPS2, and SelD reactions produced a signal at +23.2 ppm that corresponded to SeP, but interestingly, mSPS1 did not. These data provide strong evidence that the eukaryotic SPS2s synthesize SeP, as does SelD, but SPS1 does not.
Sec Biosynthesis (In Vitro)
As previous studies analyzing Sec biosynthesis had not determined whether SeP could serve directly as the selenium donor [10] [11] [12] , we chemically synthesized this compound and used it in in vitro reactions. Reactions containing SeP and O-phosphoseryl-tRNA [Ser]Sec is a true intermediate in the Sec biosynthetic pathway [13] .
Although, as noted above, SPS2 was capable of producing SeP in reactions with ATP and selenide, whereas SPS1 was not, it was important to demonstrate whether Sec could be produced on its tRNA in reactions with these components and O-phosphoseryl-tRNA [13] .
Sec Biosynthesis (In Vivo)
A previous study had established SPS1 as a mammalian SPS [27] , whereas another report had suggested that SPS1 utilized free Sec for the biosynthesis of selenoproteins [29] . Our in vitro studies described above, however, demonstrated that SPS2 is responsible for synthesizing SeP, whereas SPS1 likely has another role in selenium metabolism. To resolve these discrepancies between the earlier work [27, 29] and our more recent work [13] and to further elucidate the roles of SPS1 and SPS2 in vivo, we used RNAi technology to Fig. 1 The Sec biosynthetic pathway in eukaryotes. Abbreviations are defined in the text with the exception of SerS, which is seryl-tRNA synthetase knockdown SPS1 and SPS2 intracellularly and examine the effect(s) of their targeted removal on selenoprotein synthesis [32] . Knockdown of SPS2 in NIH3T3 cells obliterated selenoprotein synthesis, whereas knockdown of SPS1 had no affect. We then used the knockdown cells to transfect them with SPS2 or SPS1 and found that SPS2 or SelD complemented the function of the removed SPS2, but SPS1 did not. These in vivo studies demonstrated that SPS2, which synthesizes SeP [13] is essential for selenoprotein synthesis and that SPS1 likely has a more specialized function in selenium metabolism [32] .
The Sec Biosynthetic Pathway
The entire biosynthetic pathway of Sec in eukaryotes is shown in Fig. 1 . tRNA [Ser] Sec is initially aminoacylated with serine by seryl-tRNA synthetase [5, 6] . The seryl moiety is then phosphorylated by PSTK to form O-phosphoseryl-tRNA
[Ser]Sec [18] . O-phosphoseryltRNA [Ser] Sec is the substrate for SecS, which in turn hydrolyzes the phosphate group to form the acceptor molecule for SeP, and the latter reaction, which is also carried out by SecS, yields Sec. SPS2 generates the active selenium donor, SeP, from selenide and ATP [13] .
The kinase, PSTK, is not found in eubacteria, but interestingly, SelA can use Ophosphoseryl-tRNA
[Ser]Sec as a substrate. The major difference in the biosynthesis of Sec in eubacteria and the pathway described herein in eukaryotes is the extra step involving Ophosphoseryl-tRNA
[Ser]Sec synthesis, which is a substrate for SecS [13, 30] , whereas seryltRNA is the substrate for SelA in E. coli.
Concluding Remarks
The biosynthesis of Sec, (1) from the initial step involving the aminoacylation of tRNA [Ser] Sec with serine by seryl-tRNA synthetase (2) through its phosphorylation by PSTK to form Ophosphoseryl-tRNA
[Ser]Sec , (3) subsequent dephosphorylation of O-phosphoseryltRNA [Ser] Sec to yield the acceptor molecule for SeP, (4) that in turn forms Sec wherein the last two steps are carried out by SecS, has been deciphered in mammals (Fig. 1) . We also determined that SeP is synthesized by SPS2 and not by SPS1. These findings demonstrate how selenium, an essential micronutrient in the diet of humans and other mammals, becomes a component of Sec for its incorporation into protein in eukaryotes and archaea. Selenoproteins are thought to be responsible for most of the health benefits of selenium, which include preventing cancer and heart disease, delaying the aging process and the onset of AIDS in HIV positive patients, and roles in development and immune function [4] .
